Stockscreener 앱 받기
7.32
1.53%
0.11
시간 외 거래:
7.32
전일 마감가:
$7.21
열려 있는:
$7.17
하루 거래량:
953.20K
Relative Volume:
0.81
시가총액:
$1.03B
수익:
$175.51M
순이익/손실:
$-78.02M
주가수익비율:
-13.81
EPS:
-0.53
순현금흐름:
$-34.18M
1주 성능:
-2.27%
1개월 성능:
+2.81%
6개월 성능:
+43.53%
1년 성능:
-11.06%
1일 변동 폭
$7.09
$7.35
1주일 범위
$7.03
$7.485
52주 변동 폭
$4.71
$10.05
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
명칭
Aurinia Pharmaceuticals Inc
전화
250-744-2487
주소
#140, 14315 - 118 AVENUE, EDMONTON, BC
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-05-05 | 개시 | Cowen | Outperform |
| 2020-01-10 | 개시 | Jefferies | Buy |
| 2019-12-16 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-16 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 개시 | RBC Capital Mkts | Outperform |
| 2017-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 재확인 | FBR & Co. | Outperform |
| 2016-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2016-06-30 | 개시 | H.C. Wainwright | Buy |
| 2015-05-08 | 개시 | MLV & Co | Buy |
모두보기
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) are in the red if they invested three years ago - Yahoo Finance
Aurinia Pharmaceuticals (AUPH) to Release Earnings on Thursday - MarketBeat
Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024 - The Bakersfield Californian
Axonis Therapeutics Announces $115 Million Series A Financing - Quantisnow
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) surges 5.9%; individual investors who own 51% shares profited along with institutions - Simply Wall St
Objective long/short (AUPH) Report - Stock Traders Daily
Oppenheimer Downgrades Aurinia Pharmaceuticals Inc (AUPH) to a Perform from an Outperform - Knox Daily
Adversity is less terrifying than hope: Aurinia Pharmaceuticals Inc (AUPH) - SETE News
AQR Capital Management LLC Takes Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
AQR Capital Management LLC Buys Shares of 202,241 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
Aurinia Pharmaceuticals spotlights lupus nephritis drug - Investing.com India
Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024 - BioSpace
Charting the Course: Aurinia Pharmaceuticals Inc’s AUPH Stock Prospects - The InvestChronicle
Aurinia Pharmaceuticals Showcases LUPKYNIS’s Impact at ASN 2024 - TipRanks
Aurinia Pharmaceuticals spotlights lupus nephritis drug By Investing.com - Investing.com UK
Aurinia Pharmaceuticals Inc (AUPH) presents a great opportunity, but the stock is slightly undervalued - US Post News
Market Recap: Aurinia Pharmaceuticals Inc (AUPH)’s Negative Momentum, Closing at 6.84 - The Dwinnex
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Bought by SG Americas Securities LLC - MarketBeat
When the Price of (AUPH) Talks, People Listen - Stock Traders Daily
Algert Global LLC Buys 100,104 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class ActionAUPH - AsiaOne
Corporate and Individual Donations Provide Much-Needed Support to Kidney Patients Impacted by Hurricane Helene Through the American Kidney Fund’s Disaster Relief Program - GlobeNewswire Inc.
Aurinia Pharmaceuticals (NASDAQ:AUPH) shareholders are up 5.0% this past week, but still in the red over the last three years - Simply Wall St
Stonepine Capital Management LLC Takes Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
Short Interest in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Declines By 13.0% - Defense World
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Sees Large Decline in Short Interest - MarketBeat
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Could Be Less Than A Year Away From Profitability - Yahoo Finance
Armistice Capital LLC Sells 1,124,000 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
Japan approves Aurinia's lupus nephritis treatment By Investing.com - Investing.com Australia
Japan approves Aurinia's lupus nephritis treatment - Investing.com India
Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis - BioSpace
Aurinia’s Lupus Drug LUPKYNIS Wins Approval in Japan - TipRanks
Aurinia Pharma Gets Approval in Japan for Lupus Treatment - MarketWatch
Unum Group stock rises Thursday, still underperforms market - MarketWatch
Health Care Lags Market on Cyclical BiasHealth Care Roundup - MarketWatch
Waterloo Capital L.P. Decreases Stake in Ulta Beauty, Inc. (NASDAQ:ULTA) - Defense World
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat? - Zacks Investment Research
3 Small Biotech Stocks With The 'Big Mo' Right Now - Seeking Alpha
Leuthold Group LLC Invests $2.76 Million in Urban Outfitters, Inc. (NASDAQ:URBN) - Defense World
Urban Outfitters Q2 2025 Scare Led To A More Fairly Priced Stock. Still A Hold But More Interesting - Seeking Alpha
Aurinia Pharmaceuticals: LUPKYNIS Leading The Way In Lupus Nephritis Treatment - Seeking Alpha
Oppenheimer Asset Management Inc. Grows Stock Position in Ulta Beauty, Inc. (NASDAQ:ULTA) - Defense World
Unitedhealth Group Inc [UNH] gain 10.29% so far this year. What now? - The DBT News
Unum Stock: Core Business Strength Comes Into Greater Focus (UNM) - Seeking Alpha
Allurion Technologies Inc. (NYSE:ALUR) Short Interest Up 8.6% in August - Defense World
UnitedHealth Group Incorporated (UNH): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest In - Yahoo Finance
Alliance Global Partners’s latest rating for UMH stock - Knox Daily
Universal Music shares retain buy rating, price target steady on growth targets - Investing.com
Urban Outfitters (NASDAQ:URBN) Trading Up 4.1% - Defense World
Cantor Fitzgerald upgrades Universal Health Services, Inc. (UHS) stock to a Neutral - Knox Daily
UroGen Pharma reiterates stock target, outperform on strong FDA prospects - Investing.com
Aurinia Pharmaceuticals Inc (AUPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):